J Krischer

Author PubWeight™ 42.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 1998 2.39
2 Red fingers syndrome in patients with HIV and hepatitis C infection. Lancet 1996 1.66
3 Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995 1.55
4 A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990 1.53
5 Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 2000 1.44
6 Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils. Science 1994 1.39
7 Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 1992 1.36
8 Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994 1.34
9 Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 1996 1.24
10 The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia 2010 1.10
11 Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J Autoimmun 1999 1.01
12 The effect of advanced life support and sophisticated hospital systems on motor vehicle mortality. J Trauma 1984 0.93
13 Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 1996 0.91
14 Metabolic tests to determine risk for type 1 diabetes in clinical trials. Diabetes Metab Res Rev 2011 0.89
15 High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes. Diabetologia 2004 0.88
16 GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmun 1994 0.86
17 Teledermatoscopy in Switzerland: a preliminary evaluation. J Am Acad Dermatol 2000 0.85
18 Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study. Cancer 1990 0.85
19 Insulin increases the Na(+)-K(+)-ATPase alpha 2-subunit in the surface of rat skeletal muscle: morphological evidence. Am J Physiol 1993 0.85
20 Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1988 0.84
21 Obstetric anesthesia: a national survey. Anesthesiology 1986 0.83
22 Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study. Cancer 1986 0.82
23 Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer 1991 0.81
24 Quantitative analysis of cleft palate casts. A geometric study. Cleft Palate J 1974 0.81
25 Malassezia spp carriage in patients with seborrheic dermatitis. J Dermatol 1999 0.81
26 The "wobble sign" in epiluminescence microscopy as a novel clue to the differential diagnosis of pigmented skin lesions. Arch Dermatol 2000 0.81
27 [Pigmented eccrine poroma]. Ann Dermatol Venereol 1998 0.81
28 Multiple autoantibodies as predictors of Type 1 diabetes in a general population. Diabetologia 2003 0.80
29 High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. J Clin Oncol 1991 0.80
30 Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors. A phase II study from the Pediatric Oncology Group. Invest New Drugs 1988 0.79
31 The use of digital dermoscopy for the follow-up of congenital nevi: a pilot study. Pediatr Dermatol 2001 0.78
32 Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study. Cancer 1993 0.78
33 Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis. Cancer 1985 0.78
34 A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Invest New Drugs 1992 0.78
35 Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group). Invest New Drugs 1992 0.77
36 Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study. Cancer Chemother Pharmacol 1990 0.76
37 Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation. Transplant Proc 1987 0.76
38 Hyperfractionated irradiation and concurrent cisplatin in brain stem tumors: a Pediatric Oncology Group pilot study (9139). Pediatr Neurosurg 1994 0.76
39 Diagnostic pearl: unmagnified diascopy for large pigmented lesions reveals features similar to those of epiluminescence microscopy. J Am Acad Dermatol 1999 0.76
40 Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. Dermatology 1998 0.76
41 Persistent periungual erythema with telangiectasia: red fingers syndrome. Arch Dermatol 1999 0.75
42 An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDS. J Am Acad Dermatol 2000 0.75
43 [Acrosyndromes in AIDS]. Presse Med 1998 0.75
44 Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 1996 0.75
45 Chemotherapy in HIV-infected patients with Kaposi's sarcoma. Dermatology 1997 0.75
46 [Fractionation of hydrosoluble proteins from barley]. Bull Soc Chim Biol (Paris) 1966 0.75
47 Impact of PUVA therapy on HIV viremia: a pilot study. Dermatology 1997 0.75
48 Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 1987 0.75
49 Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988). Haematol Blood Transfus 1990 0.75
50 Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation. Transplant Proc 1989 0.75
51 Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study. Invest New Drugs 1991 0.75
52 Hypoluminescence microscopy of pigmented skin lesions. Melanoma Res 2000 0.75
53 [Study of a basic water-soluble protein of barley]. Bull Soc Chim Biol (Paris) 1967 0.75
54 [Multiple herpes simplex type 1 whitlow lesions]. Ann Dermatol Venereol 1999 0.75
55 Early diagnosis and specific treatment of insulin-dependent diabetes. Ann N Y Acad Sci 1993 0.75
56 A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study. J Clin Oncol 1991 0.75
57 The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML). Leukemia 1992 0.75
58 Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma. Nuklearmedizin 2007 0.75
59 [Fractionation of water-soluble proteins of barley]. Bull Soc Chim Biol (Paris) 1967 0.75
60 Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C). Invest New Drugs 1987 0.75
61 Pruritic acquired nevus of Ota. Dermatology 2013 0.75
62 Oral isotretinoin in HIV-positive women with acne: report of three cases. Dermatology 1998 0.75
63 PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study. J Neurooncol 1986 0.75
64 Chemotherapy for AIDS-related malignancies does not increase HIV viraemia. AIDS 1997 0.75
65 [Study of purified basic and water-soluble barley proteins]. Bull Soc Chim Biol (Paris) 1969 0.75
66 A pediatric gastric tube airway. Crit Care Med 1981 0.75
67 Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study. Cancer 1984 0.75
68 One rescuer CPR--a reappraisal of present recommendations for ventilation. Crit Care Med 1981 0.75
69 The use of omeprazole for resistant oesophagitis in children. Eur J Pediatr Surg 1996 0.75
70 Extensive fixed drug eruption induced by oxazepam. Arch Dermatol 1996 0.75
71 Phase II study of 13-cis-retinoic acid in pediatric patients with acute nonlymphocytic leukemia--a Pediatric Oncology Group study. J Immunother (1991) 1991 0.75